Free tool
Dividend paying stocks
We cover 21 companies that currently pay a dividend. The median market value in the group is $263.12B. Across the group, the median move over the past trading day is −1.09%. 81% of the 21 with a 200-day average trade above it. Price change over the past year runs from −11.3% to +62.8% across the middle 80 percent of the group, with a median of +27.9%.
Other lists in this group
Table
21 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.47B | Mega cap | +22.22% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $90.10M | Micro cap | −11.35% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| BALM4.SA | Baumer S.A. | $29.30M | Micro cap | +22.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.